MedPath

A clinical study on Rheumatoid Arthritis(Waja -ul- Mufasil) and its management in unani medicine

Not Applicable
Conditions
Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement
Registration Number
CTRI/2022/12/047920
Lead Sponsor
PG Dept Of MOALEJAT General Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Both gender(male & female)

2.Age >18 years <50 years

3.Morning stiffness >1hr

4.Symmetrical arthritis

5.Arthritis of 3 or more joint area

6.Rheumatoid nodule,rhuematoid factor,radiological changes

Exclusion Criteria

1.Age >50 years

2.Other joint diseases

3.Any other autoimmune diseases

4.Patient with hypertension,D.M,CVS,hepatic,Renal or pulmonary diseases

5.Pregnant and lactating mothers

drug or alcohol addict

occupational exposure to certain dusts such as silica,wood,asbestos

H/O intra-articular corticosteroid injections

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
primary outcome depend on before and after treatment of raised RA factor presence of rheumatoid noduleTimepoint: depend on before and after treatment of raised RA factor follow up after every 2 weeks
Secondary Outcome Measures
NameTimeMethod
Depends on the presence of rheumatoid nodule,raised RA factor, radiological apperanceTimepoint: outcome depend on before and after treatment of raised RA factor follow up after every 2 weeks
© Copyright 2025. All Rights Reserved by MedPath